HCLS1 Associated Protein X-1 (HAX1) (Middle Region) Peptid
Kurzübersicht für HCLS1 Associated Protein X-1 (HAX1) (Middle Region) Peptid (ABIN8102198)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- HAX1 Peptide - middle region
-
Sequenz
- QPAPDWGSQR PFHRFDDVWP MDPHPRTRED NDLDSQVSQE GLGPVLQPQP
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-HAX1 Antibody(ARP52142_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- HAX1 (HCLS1 Associated Protein X-1 (HAX1))
-
Hintergrund
-
Background Information: HAX1 is known to associate with hematopoietic cell-specific Lyn substrate 1, a substrate of Src family tyrosine kinases. It also interacts with the product of the polycystic kidney disease 2 gene, mutations in which are associated with autosomal-dominant polycystic kidney disease, and with the F-actin-binding protein, cortactin. It was earlier thought that this gene product is mainly localized in the mitochondria, however, recent studies indicate it to be localized in the cell body. Mutations in this gene result in autosomal recessive severe congenital neutropenia, also known as Kostmann disease.
Alternative Symbols: HCLSBP1, HS1BP1, SCN3
-
Molekulargewicht
- 25kDa
-
Gen-ID
- 10456
-
NCBI Accession
- NP_001018238
-
UniProt
- O00165
Target
-